North America, Health , Life Science, Science
Thinking outside the embryo
By John Hockenberry, Adaora Udoji, Chelsea Merz
July 23, 2008, 06:40 AM
Since 2001, when a federal funding freeze crippled research into the use of human embryonic stem cells to treat a host of congenital and degenerative conditions, molecular biologists have searched for a viable alternative. Now, they may have found a way. By reprogramming adult skin cells, researchers have produced stem cells that bypass the political and ethical stumbling blocks. But all is not perfect. In recent studies, the cells produced tumors in mice.
More on North America
More on Health
More on Life Science
More on Science
More by John Hockenberry
More by Adaora Udoji
- In 2004, rule change at SEC set the stage for a credit crisis
- The Takeaway for October 6, 2008
- Consumer spending is the latest victim of the financial crisis
- The Takeaway for October 3, 2008
- The long history of federal and corporate bailouts
- Today's conversation
- Blogging movers and shakers review the vice-presidential debate
- The Takeaway for October 1, 2008
- No clear winner after vice-presidential candidates Palin and Biden debate
- The Takeaway for October 2, 2008
The show is a co-production of WNYC Radio and Public Radio International,
in collaboration with The BBC World Service, New York Times Radio and WGBH Boston.
